Hyperfine Expands Portable MRI Footprint with European Launch of Next-Gen Swoop System

  • Hyperfine launched its next-generation Swoop® Model 2 portable MRI system in Europe after securing CE and UKCA approvals.
  • The system is now commercially available across initial European markets, with plans to expand to all represented markets by year-end.
  • Inclusion in UniHA’s procurement listing enables broader adoption within France’s public healthcare system.
  • Professor Steve Williams of King’s College London highlighted the transformative image quality improvements in the new model.

Hyperfine’s European expansion positions it as a disruptor in the neuroimaging space, challenging conventional high-field MRI systems with its portable, AI-powered alternative. The UniHA procurement listing represents a significant validation of its technology within public healthcare systems, potentially opening doors to similar national procurement frameworks across Europe.

Adoption Pace
The pace at which European hospitals integrate the Swoop® system into clinical workflows will determine its market penetration.
Regulatory Momentum
Whether Hyperfine can maintain this regulatory approval momentum in additional global markets.
Competitive Response
How traditional MRI manufacturers may react to Hyperfine’s expanding footprint in portable neuroimaging.